Solange Corriol‐Rohou
AstraZeneca (France)(FR)MNM Consulting (France)(FR)
Publications by Year
Research Areas
Pharmaceutical studies and practices, Health Systems, Economic Evaluations, Quality of Life, Childhood Cancer Survivors' Quality of Life, Adolescent and Pediatric Healthcare, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity(2021)93 cited
- → Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)(2017)67 cited
- → Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments(2021)41 cited
- → Objectively Measured Physical Activity as a COPD Clinical Trial Outcome(2021)38 cited
- → Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation(2017)38 cited
- → Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines(2020)36 cited
- → On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective(2022)30 cited
- → Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018(2020)24 cited
- → Patterns of Physical Activity Progression in Patients With COPD(2020)17 cited
- → Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation(2022)15 cited